Balanced news tone
News Sentiment
QIA sentiment intelligence
Qiagen N.V. news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Weighted score
48
Balanced news tone
28 relevant articles
News tone and price action are not far from neutral.
76/100 classification confidence.
directly relevant articles
high-authority source matches
+0.5% over one week, +6.1% over four weeks, trend inactive, and near fair-value range.
Qiagen Stock - Saturday focus on long-term strategy and growth drivers
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Primary event
Market update
76/100 classification
One-week reaction
0.5%
Price digesting
Trend fit
Trend inactive
6.1% over four weeks
Fair value
-17.1%
Near fair-value range
Sentiment Mix
Positive, neutral, negative
Positive
3
Neutral
20
Negative
5
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
Above 50
Neutral zone
Below 50
News Tape
Relevant headlines
AD HOC NEWS
Direct company coverage
Qiagen Stock - Saturday focus on long-term strategy and growth drivers
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 20 Jun 2026 13:26
- Source
- AD HOC NEWS
AD HOC NEWS
Direct company coverage
Qiagen Stock - Friday review and sector comparison
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 19 Jun 2026 14:43
- Source
- AD HOC NEWS
AD HOC NEWS
Direct company coverage
Qiagen N.V. Stock (NL0012169213): Analyst Views And Fundamentals In Focus
- Tone
- Neutral 50/100
- Event
- Analyst action
- Published
- 16 Jun 2026 19:49
- Source
- AD HOC NEWS
AD HOC NEWS
Direct company coverage
Qiagen N.V. Stock (NL0012169213): Stifel sticks to Hold after digital PCR update
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 16 Jun 2026 14:45
- Source
- AD HOC NEWS
Investing.com Australia
Direct company coverage
Stifel reiterates Qiagen stock Hold rating after dPCR event By Investing.com
- Tone
- Neutral 50/100
- Event
- Analyst action
- Published
- 16 Jun 2026 12:50
- Source
- Investing.com Australia
AD HOC NEWS
Direct company coverage
Qiagen N.V. Stock (NL0012169213): Sector Check On Diagnostics Player
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 12 Jun 2026 07:45
- Source
- AD HOC NEWS
AD HOC NEWS
Direct company coverage
Qiagen N.V. stock (NL0012169213): focus on molecular diagnostics and steady demand drivers
- Tone
- Neutral 50/100
- Event
- Macro sensitivity
- Published
- 09 Jun 2026 19:22
- Source
- AD HOC NEWS
AD HOC NEWS
Direct company coverage
Qiagen N.V. stock (NL0012169213): Diagnostics player stays in focus after latest quarterly update
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 08 Jun 2026 17:59
- Source
- AD HOC NEWS
AD HOC NEWS
Direct company coverage
Qiagen N.V. stock (NL0012169213): Diagnostic specialist updates investors after recent earnings
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 08 Jun 2026 10:43
- Source
- AD HOC NEWS
AD HOC NEWS
Direct company coverage
Qiagen N.V. stock (NL0012169213): Shares in focus after Jefferies conference appearance and law firm
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 03 Jun 2026 07:00
- Source
- AD HOC NEWS
Seeking Alpha
Direct company coverage
Qiagen N.V. (QGEN) Presents at Deutsche Bank German Corporate Conference - Slideshow (NYSE:QGEN) 2026-06-01
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 01 Jun 2026 07:00
- Source
- Seeking Alpha
AD HOC NEWS
Direct company coverage
Qiagen N.V. stock (NL0012169213): steady after Q1 2026 update while analysts refine outlook
- Tone
- Neutral 50/100
- Event
- Guidance
- Published
- 01 Jun 2026 07:00
- Source
- AD HOC NEWS
AD HOC NEWS
Direct company coverage
Qiagen N.V. stock (NL0012169213): UBS stake disclosure and AFM voting rights notice keep insider own
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 30 May 2026 07:00
- Source
- AD HOC NEWS
AD HOC NEWS
Direct company coverage
Qiagen N.V. stock (NL0012169213): Diagnostics group under scrutiny after investor investigation upda
- Tone
- Negative 34/100
- Event
- Regulatory and legal
- Published
- 29 May 2026 07:00
- Source
- AD HOC NEWS
AD HOC NEWS
Direct company coverage
Qiagen N.V. stock (NL0012169213): Diagnostics specialist in focus after latest earnings
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 28 May 2026 07:00
- Source
- AD HOC NEWS
AD HOC NEWS
Direct company coverage
Qiagen N.V. stock (NL0012169213): diagnostics player in focus after solid first-quarter update
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 27 May 2026 07:00
- Source
- AD HOC NEWS
AD HOC NEWS
Direct company coverage
Qiagen N.V. stock (NL0012169213): Jefferies cuts target as diagnostics group navigates post-pandemic
- Tone
- Negative 34/100
- Event
- Analyst action
- Published
- 24 May 2026 07:00
- Source
- AD HOC NEWS
AD HOC NEWS
Direct company coverage
Qiagen stock (NL0012169213): Q1 update and share-price backdrop
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 21 May 2026 07:00
- Source
- AD HOC NEWS
AD HOC NEWS
Direct company coverage
Qiagen N.V. stock (NL0012169213): Diagnostics group lifts 2026 outlook after first?quarter earnings
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 20 May 2026 07:00
- Source
- AD HOC NEWS
Stock Titan
Direct company coverage
New QIAGEN AI lab assistant is designed to speed experiment planning
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 20 May 2026 07:00
- Source
- Stock Titan
AD HOC NEWS
Direct company coverage
Qiagen N.V. stock (NL0012169213): Q1 earnings meet EPS but miss revenue
- Tone
- Negative 34/100
- Event
- Earnings
- Published
- 11 May 2026 07:00
- Source
- AD HOC NEWS
marketscreener.com
Direct company coverage
German Shares Slip; Qiagen Tumbles on Outlook Downgrade
- Tone
- Negative 34/100
- Event
- Guidance
- Published
- 28 Apr 2026 07:00
- Source
- marketscreener.com
European Biotechnology Magazine
Direct company coverage
Takeover rumours at Qiagen fuel share price surge
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 21 Jan 2026 08:00
- Source
- European Biotechnology Magazine
Market source
Direct company coverage
QIAGEN Announces Details for Completion of Synthetic Share Repurchase of up to Approximately $500 Million
- Tone
- Neutral 50/100
- Event
- Capital return
- Published
- 18 Dec 2025 08:00
- Source
- Market source
CNBC
Direct company coverage
Activist Fivespan has a stake in Qiagen. Here are 3 levers to boost the company’s growth and improve value
- Tone
- Positive 66/100
- Event
- Deals and strategy
- Published
- 03 May 2025 07:00
- Source
- CNBC
Reuters
Direct company coverage
Qiagen cuts outlook on weaker COVID-19 testing trends, shares fall
- Tone
- Negative 6/100
- Event
- Guidance
- Published
- 12 Jul 2021 07:00
- Source
- Reuters
Reuters
Direct company coverage
Qiagen NV
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 30 Jun 2021 14:34
- Source
- Reuters
Thermo Fisher Scientific
Direct company coverage
Thermo Fisher Scientific Publishes Offer Document for Voluntary Tender Offer for All Ordinary Shares of QIAGEN N.V.
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 18 May 2020 07:00
- Source
- Thermo Fisher Scientific